Medical leaders reacted swiftly to the Supreme Court’s decision on affirmative a...
Carrie Harney, the vice president of government and regulatory Affairs at US Pha...
Genprex has announced that the FDA has granted fast-track designation for Reqors...
Pfizer has announced that the FDA has approved Ngenla (somatrogon-ghla), a paedi...
Cellusion shares Phase I/II clinical development plans for its bullous keratopat...
Research has shown that GLP-1RAs may have the potential to treat chronic metabol...
Experts warn caution around CRISPR gene editing technology on human embryos as i...
While Alvotech aims to file a new application, the FDA's rejection delays the dr...
AstraZeneca has announced impressive results for its STRIDE regimen, significant...
The FDA has announced that Lantidra, a cellular therapy for type 1 diabetes, has...
The T-cell therapeutics company expects to be listed on the NYSE after deal comp...
In Trump fashion, the former president claimed in a video announcement that he i...
“Some of these things are just low-hanging fruit,” said David Jones, professor a...
“If this vaccine could reduce the disease by 50%, that has tremendous implicatio...
The smoke from Canadian fires illuminates the lack of government policies and pr...
The FDA declined to approve a higher-dose version of a Regeneron Pharmaceuticals...
